ATE173162T1 - Medizinische vorrichtung zur verabreichung von aktivsubstanzen oder arzneistoffen in sehr niedriger dosis, insbesondere von homöopatischen arzneistoffen - Google Patents
Medizinische vorrichtung zur verabreichung von aktivsubstanzen oder arzneistoffen in sehr niedriger dosis, insbesondere von homöopatischen arzneistoffenInfo
- Publication number
- ATE173162T1 ATE173162T1 AT94112012T AT94112012T ATE173162T1 AT E173162 T1 ATE173162 T1 AT E173162T1 AT 94112012 T AT94112012 T AT 94112012T AT 94112012 T AT94112012 T AT 94112012T AT E173162 T1 ATE173162 T1 AT E173162T1
- Authority
- AT
- Austria
- Prior art keywords
- medicinal
- administration
- medical device
- homeopatical
- active substances
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 3
- 229940079593 drug Drugs 0.000 abstract 3
- 230000001632 homeopathic effect Effects 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 239000012982 microporous membrane Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITRM930591A IT1261849B (it) | 1993-09-02 | 1993-09-02 | Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE173162T1 true ATE173162T1 (de) | 1998-11-15 |
Family
ID=11401933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94112012T ATE173162T1 (de) | 1993-09-02 | 1994-08-02 | Medizinische vorrichtung zur verabreichung von aktivsubstanzen oder arzneistoffen in sehr niedriger dosis, insbesondere von homöopatischen arzneistoffen |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5683712A (de) |
| EP (1) | EP0641561B1 (de) |
| JP (1) | JPH07165566A (de) |
| KR (1) | KR950007808A (de) |
| AT (1) | ATE173162T1 (de) |
| CA (1) | CA2129760A1 (de) |
| DE (1) | DE69414502T2 (de) |
| DK (1) | DK0641561T3 (de) |
| ES (1) | ES2125380T3 (de) |
| GR (1) | GR3029308T3 (de) |
| IT (1) | IT1261849B (de) |
| ZA (1) | ZA946698B (de) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6475514B1 (en) | 1998-12-03 | 2002-11-05 | Andrew Blitzer | Athletic patch |
| GB2354636A (en) * | 1999-09-25 | 2001-03-28 | Ibm | Mounting chips on substrates |
| FR2806910B1 (fr) * | 2000-04-03 | 2003-01-24 | Dolisos Lab | Procede d'inactivation virale de solutions hydro-alcooliques |
| RU2181297C2 (ru) * | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
| US20030022206A1 (en) * | 2001-05-16 | 2003-01-30 | Kay Robert A. | Method of characterizing a homeopathic preparation |
| US20040009180A1 (en) * | 2002-07-11 | 2004-01-15 | Allergan, Inc. | Transdermal botulinum toxin compositions |
| UA76638C2 (en) | 2002-08-02 | 2006-08-15 | Oleh Illich Epshtein | Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon |
| UA76641C2 (uk) * | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози |
| UA76640C2 (uk) * | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Спосіб корекції патологічних імунних реакцій та гомеопатичний лікарський засіб |
| UA76639C2 (uk) * | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій |
| US20050255139A1 (en) * | 2004-05-14 | 2005-11-17 | Hurd Jonathan L | Polymeric compositions with embedded pesticidal desiccants |
| US20060188558A1 (en) * | 2005-02-18 | 2006-08-24 | Mylan Technologies, Inc. | Transdermal systems having control delivery system |
| CN101374498A (zh) | 2005-12-01 | 2009-02-25 | 麻萨诸塞州洛厄尔大学 | 肉毒杆菌纳米乳液 |
| US9486408B2 (en) | 2005-12-01 | 2016-11-08 | University Of Massachusetts Lowell | Botulinum nanoemulsions |
| RU2309732C1 (ru) * | 2006-03-13 | 2007-11-10 | Олег Ильич Эпштейн | Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата |
| EP2015773A4 (de) | 2006-04-27 | 2010-05-05 | Anterios Inc | Prüfung der effekte topischer verabreichung chemisch denervierender pharmazeutika |
| EA200802440A1 (ru) * | 2006-06-06 | 2009-06-30 | Олег Ильич ЭПШТЕЙН | Лекарственное средство для лечения ожирения, сахарного диабета и заболеваний с нарушением толерантности к глюкозе |
| WO2008070538A2 (en) | 2006-12-01 | 2008-06-12 | Anterios, Inc. | Micellar nanoparticles comprising botulinum toxin |
| SG10201607909WA (en) | 2006-12-01 | 2016-11-29 | Anterios Inc | Peptide nanoparticles and uses therefor |
| US8940326B2 (en) | 2007-03-19 | 2015-01-27 | Vita Sciences Llc | Transdermal patch and method for delivery of vitamin B12 |
| CN101765423B (zh) | 2007-05-31 | 2014-08-06 | 安特里奥公司 | 核酸纳米粒子和其用途 |
| US20090047334A1 (en) * | 2007-08-13 | 2009-02-19 | Patricia Williams | Transdermal patch for extended delivery of calcium |
| KR102080429B1 (ko) | 2008-06-26 | 2020-02-21 | 안테리오스, 인코퍼레이티드 | 경피 운반 |
| EA030542B1 (ru) | 2010-07-15 | 2018-08-31 | Олег Ильич ЭПШТЕЙН | Комбинированная фармацевтическая композиция и способ лечения заболеваний или состояний желудочно-кишечного тракта функциональной этиологии |
| EA030566B1 (ru) | 2010-07-15 | 2018-08-31 | Олег Ильич ЭПШТЕЙН | Способ повышения терапевтической эффективности активированной-потенцированной формы антитела к эндогенной биомолекуле и фармацевтическая композиция |
| US8637034B2 (en) | 2010-07-15 | 2014-01-28 | Oleg I. Epshtein | Pharmaceutical compositions comprising activated-potentiated antibodies to interferon-gamma and S100 protein |
| KR101906132B1 (ko) | 2010-07-17 | 2018-10-10 | 메르크 파텐트 게엠베하 | 침투 및 작용의 증진 |
| PH12013500142A1 (en) | 2010-07-21 | 2013-03-11 | Oleg Iliich Epshtein | Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition |
| CA2805963A1 (en) | 2010-07-21 | 2012-01-26 | Oleg Iliich Epshtein | A method of treating attention deficit hyperactivity disorder |
| EP2667945A1 (de) | 2011-01-24 | 2013-12-04 | Anterios, Inc. | Ölzusammensetzungen |
| TR201905477T4 (tr) | 2011-01-24 | 2019-05-21 | Anterios Inc | Nano-parçacık bileşimler. |
| JP5943258B2 (ja) | 2011-01-24 | 2016-07-05 | アンテリオス, インコーポレイテッド | ナノ粒子組成物、その製剤およびその使用 |
| US10022335B2 (en) | 2011-03-03 | 2018-07-17 | Nancy Josephine Polich | Homeopathic therapeutic method and compositions |
| US20120225018A1 (en) * | 2011-03-03 | 2012-09-06 | Nancy Josephine Polich | Homeopathic therapeutic method and compositions |
| HRP20181286T1 (hr) | 2011-03-10 | 2018-10-05 | Rigel Pharmaceuticals, Inc. | 2,4 supstituirani pirimidindiamini za uporabu kod diskoidnog lupusa |
| US9603898B2 (en) | 2011-03-23 | 2017-03-28 | Deseret Biologicals, Inc. | Formulations of diluted amino acid segments and methods for making same |
| BE1020027A3 (fr) * | 2011-06-23 | 2013-04-02 | Jean Pierre Mageren | Compositions homeopathiques pour le traitement des douleurs du dos et des sciatiques. |
| WO2013163176A1 (en) | 2012-04-23 | 2013-10-31 | Allertein Therapeutics, Llc | Nanoparticles for treatment of allergy |
| KR101365321B1 (ko) * | 2012-05-22 | 2014-02-20 | 제일약품주식회사 | 매트릭스내 비스테로이드성 소염진통제의 농도구배를 이용하여 경피투과도를 향상시킨 패취제 |
| JP2015528501A (ja) | 2012-09-12 | 2015-09-28 | ライジェル ファーマシューティカルズ, インコーポレイテッド | 白斑の治療法 |
| KR102233251B1 (ko) | 2013-04-03 | 2021-03-26 | 엔-폴드 엘엘씨 | 신규 나노입자 조성물 |
| CA2947027A1 (en) | 2014-05-01 | 2015-11-05 | Anterios, Inc. | Methods to treat, prevent, and improve skin conditions |
| ES2781332T3 (es) | 2015-07-24 | 2020-09-01 | Glaxo Group Ltd | Tratamiento para el vitíligo |
| EP3541358A1 (de) | 2016-11-21 | 2019-09-25 | Eirion Therapeutics, Inc. | Transdermale verabreichung von grossen wirkstoffen |
| BR112020012641A2 (pt) | 2017-12-20 | 2020-12-01 | Allergan, Inc. | polipeptídeos de domínio de ligação celular de toxina de botulinum e métodos de uso para rejuvenescimento da pele |
| JP7777448B2 (ja) | 2018-09-13 | 2025-11-28 | エイリオン セラピューティクス, インコーポレイテッド | プラスミノーゲンアクチベーターインヒビター1(plasminogen activator inhibitor 1)(PAI-1)阻害剤(inhibitor)の使用 |
| SG11202102478SA (en) | 2018-09-13 | 2021-04-29 | Eirion Therapeutics Inc | Plasminogen activator inhibitor 1 (pai-1) inhibitors and uses therefor |
| MX2021006102A (es) | 2018-12-03 | 2021-09-21 | Eirion Therapeutics Inc | Suministro mejorado de agentes grandes. |
| EP3969038A1 (de) | 2019-05-14 | 2022-03-23 | Eirion Therapeutics, Inc. | Verzögerung der spitzenwirkung und/oder verlängerung der dauer der reaktion |
| WO2021003315A1 (en) | 2019-07-02 | 2021-01-07 | Rowley Clifford T | Transdermal patch providing improved permeability |
| EP4007581A4 (de) | 2019-08-02 | 2023-10-25 | Enterin, Inc. | Dosierungsprotokolle und regimes zur aminosterolbehandlung |
| WO2025064449A1 (en) | 2023-09-18 | 2025-03-27 | Eirion Therapeutics, Inc. | Topical compositions and uses of pai-1 inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4060084A (en) * | 1976-09-07 | 1977-11-29 | Alza Corporation | Method and therapeutic system for providing chemotherapy transdermally |
| US4605548A (en) * | 1983-05-31 | 1986-08-12 | Nitto Electric Industrial Co., Ltd. | Drug administration material |
| US4788064A (en) * | 1987-07-31 | 1988-11-29 | Warner-Lambert Company | Transdermal delivery system |
| WO1992006701A1 (en) * | 1990-10-18 | 1992-04-30 | Huffstutler, M., Conrad, Jr. | Preparation of concentrated fluid symphytum extracts, therapeutic forms and methods of use |
-
1993
- 1993-09-02 IT ITRM930591A patent/IT1261849B/it active IP Right Grant
-
1994
- 1994-08-02 EP EP94112012A patent/EP0641561B1/de not_active Expired - Lifetime
- 1994-08-02 ES ES94112012T patent/ES2125380T3/es not_active Expired - Lifetime
- 1994-08-02 DK DK94112012T patent/DK0641561T3/da active
- 1994-08-02 AT AT94112012T patent/ATE173162T1/de not_active IP Right Cessation
- 1994-08-02 DE DE69414502T patent/DE69414502T2/de not_active Expired - Fee Related
- 1994-08-09 CA CA002129760A patent/CA2129760A1/en not_active Abandoned
- 1994-08-24 KR KR1019940020906A patent/KR950007808A/ko not_active Abandoned
- 1994-09-01 ZA ZA946698A patent/ZA946698B/xx unknown
- 1994-09-02 JP JP6209599A patent/JPH07165566A/ja active Pending
-
1995
- 1995-09-14 US US08/528,162 patent/US5683712A/en not_active Expired - Fee Related
-
1999
- 1999-02-05 GR GR990400390T patent/GR3029308T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH07165566A (ja) | 1995-06-27 |
| EP0641561A3 (de) | 1995-09-27 |
| ES2125380T3 (es) | 1999-03-01 |
| EP0641561B1 (de) | 1998-11-11 |
| ITRM930591A1 (it) | 1995-03-02 |
| KR950007808A (ko) | 1995-04-15 |
| DK0641561T3 (da) | 1999-07-26 |
| GR3029308T3 (en) | 1999-05-28 |
| ZA946698B (en) | 1995-05-02 |
| EP0641561A2 (de) | 1995-03-08 |
| DE69414502D1 (de) | 1998-12-17 |
| IT1261849B (it) | 1996-06-03 |
| US5683712A (en) | 1997-11-04 |
| ITRM930591A0 (it) | 1993-09-02 |
| CA2129760A1 (en) | 1995-03-03 |
| DE69414502T2 (de) | 1999-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69414502D1 (de) | Medizinische Vorrichtung zur Verabreichung von Aktivsubstanzen oder Arzneistoffen in sehr niedriger Dosis, insbesondere von homöopatischen Arzneistoffen | |
| DE69327628D1 (de) | Transdermales arzneimittelverabreichungssystem | |
| KR900701274A (ko) | 남용 가능성을 감소시킨 용량 제형 | |
| DE3881340D1 (de) | Vorrichtung zur transdermalen applikation von medikamenten. | |
| DK0724885T3 (da) | Pernasal sammensætning og pernasalt præparat indeholdende dette | |
| ES2060593T3 (es) | Sistema de aporte de farmacos. | |
| ES2062093T3 (es) | Emplasto de varias capas. | |
| ATE234602T1 (de) | Verabreichungsform zur abgabe von steigenden wirkstoffdosen | |
| DK0831827T3 (da) | Nye formuleringer til transdermal levering af pergolid | |
| DE3778223D1 (de) | Biologisch erodierbares system mit gesteuerter freisetzung des arzneiwirkstoffes. | |
| DE69017596D1 (de) | Verwendung eines Opiatantagonisten zur Herstellung eines transdermal zu verabreichenden Arzneimittels sowie eine Vorrichtung zur transdermalen Verabreichung. | |
| DE69332066D1 (de) | Pflaster zur transdermalen verabreichung eines medikaments | |
| ATE161735T1 (de) | Pharmazeutisches mittel zur behandlung von mit herpes-zoster assoziierten schmerzen und von postherpetischen neuralgien mittels lokaler anwendung von lokalanästhetika | |
| DE3669828D1 (de) | Mittel und vorrichtung zur steuerung der transdermalen penetration topischer und systematischer wirkstoffe. | |
| KR900015761A (ko) | 경피성 단일체 시스템 | |
| DE3879853D1 (de) | Klebstoffzusammensetzung, zusammensetzung mit kontrollierter wirkstofffreisetzung und system zur transdermalen anwendung von arzneien. | |
| DE59808186D1 (de) | Transdermales therapeutisches system zur abgabe von hormonen | |
| DK183389A (da) | Fremgangsmaade til fremstilling af en administrerings- og/eller doseringsform for medicinsk aktive materialer | |
| Monkhouse et al. | Transdermal drug delivery-problems and promises | |
| KR900013993A (ko) | 활성물질의 국소 또는 계통적 투여를 위한 단계적 약물 방출을 나타내는 경피 시스템 및 그 용도 | |
| AU6229086A (en) | Novel transdermal anti-anginal pharmaceutical dosage unit and process for its administration |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |